Episode Details

Back to Episodes
Zyrtec Recall Alert: Ranitidine Contamination | Burlington News

Zyrtec Recall Alert: Ranitidine Contamination | Burlington News

Published 2 weeks, 3 days ago
Description

A major recall is underway for generic Zyrtec allergy tablets after contamination with ranitidine, the active ingredient in Zantac, was discovered—potentially triggering life-threatening allergic reactions. The FDA issued the alert this past Saturday, affecting 5mg tablets with specific lot numbers; consumers should check the FDA website to verify their medication. The contamination was caught by a vigilant pharmacy tech who spotted the wrong-colored pills. While no adverse reactions have been reported yet, anyone who’s taken the recalled meds and feels unwell should contact their doctor immediately and report it online. This incident underscores the critical need for consumer vigilance and supply chain accountability in pharmaceuticals.

Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/909abb4943fa1fb0

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us